Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Rifampicin + Isoniazid
- Therapeutic area
- Anti-infectives
- Drug class
- Antimycobacterials
- ATC
- J04AM
- Strength
- 300 mg + 150 mg
- Dosage form
- Tablet
- Pack
- 32’s
- Registration no.
- 005559
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-09-23 03:18
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
No change in the official DRAP price is recorded for this pack (32’s). Current price PKR 1,280.92, effective 1 Jul 2024.
Cite this price history
MedInfoBase. RIFINAH 300 mg + 150 mg, 32’s: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/rifinah-300-mg-150-mg-005559-32s-pacific-pharmaceutical-ltd/ (accessed 23 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 1,280.92 | 2024-07-01 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 005559Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.
